TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Commuting every day in a car Read more…
Transcript: Caroline Woods:Joining me now is Nancy Tengler, CEO, Laffer Tengler Investments. Nancy, great to have you back at the desk. Nancy Tengler:I know Caroline, thanks for having me. Caroline Woods:We’re very happy to have Read more…
SpaceX (SPCX) stock investors spent the lion’s share of the post-IPO period questioning if its expensive AI push deserves any value. Subsequently, the stock’s steep slide sharpened that skepticism. Nevertheless, analysts felt SpaceX was being Read more…
Americans saving for retirement would be wise to consider risks involved with their 401(k) money — and bestselling personal finance author Dave Ramsey warns Americans to watch out for big mistakes to avoid. Among the Read more…
The Transportation Security Administration’s (TSA) three-one-one liquid rule, put in place in the United States in 2006 in response to the 9/11 attacks, continues to require travelers passing through a domestic airport to keep all liquids, gels, Read more…
T-Mobile made a significant change last week by rolling out new wireless plans under its new “Nothing” initiative to attract price-conscious customers. However, its new offerings lack two generous customer perks that were once included Read more…
Most corporations have headquarters; few have museums devoted to the cultural impact their products have had around the world. But then again, few corporations are Coca-Cola, the world’s largest beverage company. The company has had Read more…
2026 has been a hard year to work in tech, even at companies posting record revenue. Salesforce trimmed its support division nearly in half earlier this year, then quietly cut more jobs in an AI-related Read more…
In my neighborhood, a successful restaurant that did a massive weekend brunch business closed over a lease dispute with the owner of its building. The restaurant was willing to pay an increase, but not as Read more…
Jazz Pharmaceuticals (JAZZ) just made a bet on a disease that many investors have never heard of. On August 10, the drugmaker agreed to buy privately held Actio Biosciences. The prize is an experimental medicine Read more…